Category: Cancer Treatment
Cancer Treatment market research reports by DelveInsight
-
B-cell Lymphoma- Pipeline Insight, 2025
DelveInsight’s, “B-cell Lymphoma- Pipeline Insight, 2025” report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutic ... Read More
-
Metastatic Colorectal Cancer - Pipeline Insight, 2025
DelveInsight’s, “Metastatic Colorectal Cancer - Pipeline Insight, 2025” report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the US accounted for the maximum share of the Ewing sarcoma Treatment Market in the 7MM, i.e., nearly 53%. A molecular-targeted therapy with minimal risk of late toxicities would be beneficial because most Ewing sarcoma Patients are under 20 years old. Although there is no st ... Read More
-
Advanced Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Advanced Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2025
DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Refractory Metastatic Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory Metastatic Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The total market size in the 7MM for multiple myeloma was estimated to be nearly USD 21,300 million in 2023, which is expected to show positive growth by 2034, owing to rise in incident cases, label expansion and penetration of current therapies in earlier lines, high adoption of newe ... Read More
-
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeli ... Read More
-
Pancreatic Cancer - Competitive Landscape, 2024
Pancreatic Cancer - Competitive Landscape, 2024 DelveInsight’s, “Pancreatic Cancer - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 190+ drugs in Pancreatic Cancer Competitive landscape. It covers the therapeutics assessment by product type, stage, rou ... Read More
-
Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030
Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030 Immunohistochemistry (IHC) Market by Product Type (Instruments, Reagents & Kits, and Services), Application (Diagnostic, Research, and Forensic), End-User (Hospitals & Diagnostic Laboratories, Academic & R ... Read More
-
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024 DelveInsight’s, “PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 200+ drugs in PD-1 and PD-L1 Inhibitors Competitive landscape. It covers the therapeutics assessment by ... Read More
-
Cutaneous T-cell lymphoma - Pipeline Insight, 2024
Cutaneous T-cell lymphoma - Pipeline Insight, 2024 DelveInsight’s, “Cutaneous T-cell lymphoma- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Cutaneous T-cell lymphoma pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More
-
Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030
Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 Gastric Cancer Diagnostics Market by Product Type (Instruments, Reagents & Kits), Test Type (Imaging Test [Upper Endoscopy, Barium Swallow/X-Rays, CT Scan, Laparoscopy, MRI, Stomach Ultrasound, and Others ... Read More
-
Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology And Market Forecast - 2034
Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, the total diagnosed prevalent cases of presbyopia in the 7MM, were ~278 million; the number of these cases is expected to increase by 2034. In 2023 ... Read More
-
Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast - 2034
Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast - 2034 Key Highlights In 2023, in the 7MM there were around 1,500,000 diagnosed prevalent cases of NMIBC. In 2023, the highest cases of NMIBC were at stage Ta, followed by T1 and Tis in the United States, while PUN-LMP accounted for ... Read More
-
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030 Cancer Monoclonal Antibodies Market by Type (Humanized Antibodies, Chimeric Antibodies, Murine Antibodies), Application (Blood Cancer, Breast Cancer, Liver Cancer, Colorectal Cancer, and Others), End-Us ... Read More
-
Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024
Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024 DelveInsight’s, “Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024” report provides comprehensive insights about 22+ companies and 25+ pipeline drugs in Untreated Metastatic or Unresectable Melanoma pipeline la ... Read More
-
Chemotherapy Induced Pain – Market Insight, Epidemiology, and Market Forecast – 2034
Chemotherapy Induced Pain – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Chemotherapy Induced Pain – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Chemotherapy Induced Pain, historical and forecasted epidemio ... Read More
-
Nasopharyngeal Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
Nasopharyngeal Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Nasopharyngeal Carcinoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Nasopharyngeal Carcinoma, historical and forecasted epidemiolog ... Read More
-
Low-Grade Upper Tract Urothelial Cancer (LG UTUC) – Market Insight, Epidemiology, and Market Forecast – 2034
Low-Grade Upper Tract Urothelial Cancer (LG UTUC) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Low-Grade Upper Tract Urothelial Cancer (LG UTUC) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Low-Grade Upp ... Read More
-
Hodgkin's lymphoma (HL) – Market Insight, Epidemiology, and Market Forecast – 2034
Hodgkin's lymphoma (HL) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Hodgkin's lymphoma (HL) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Hodgkin's lymphoma (HL), historical and forecasted epidemiology a ... Read More
-
HER2+ Gastric Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
HER2+ Gastric Cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""HER2+ Gastric Cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the HER2+ Gastric Cancer, historical and forecasted epidemiology as well as ... Read More
-
CNS Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034
CNS Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""CNS Lymphoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the CNS Lymphoma, historical and forecasted epidemiology as well as the CNS Lymphoma market ... Read More
-
T-Cell Prolymphocytic Leukemia – Market Insight, Epidemiology, and Market Forecast – 2034
T-Cell Prolymphocytic Leukemia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""T-Cell Prolymphocytic Leukemia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the T-Cell Prolymphocytic Leukemia, historical and fore ... Read More
-
Osteosarcoma – Market Insight, Epidemiology, and Market Forecast – 2034
Osteosarcoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Osteosarcoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Osteosarcoma, historical and forecasted epidemiology as well as the Osteosarcoma market ... Read More
Research Assistance
